More on ALMR

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (8.0 Score)

Upcoming Events

- Earnings (11/3/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

(NQ:ALMR)
Delayed: 29.87 +1.71 (6.07%)
Prev. Close $28.16  
Open$28.39 
52 Wk High$ 
52 Wk Low$ 
Day High$30.11 
Day Low$28.16 
P/E N/A  
EPS$ 
Volume247,798 


Oct 19, 2026 04:30 PM Form 4 Alamar Biosciences, Inc. For: Oct 15 Filed by: Qiming Venture Partners VIII Investments, LLC
Oct 14, 2026 08:33 PM Form 144 Alamar Biosciences, Inc. Filed by: Qiming Venture Partners VIII-HC, L.P.
Oct 14, 2026 08:23 PM Form 144 Alamar Biosciences, Inc. Filed by: Qiming Venture Partners VIII Investments, LLC
Oct 14, 2026 08:21 PM Form 144 Alamar Biosciences, Inc. Filed by: Qiming Venture Partners VI, L.P.
Oct 14, 2026 08:15 PM Form 144 Alamar Biosciences, Inc. Filed by: Qiming Managing Directors Fund VI, L.P.
Oct 8, 2026 04:05 PM Alamar Biosciences to Report Third Quarter 2026 Financial Results on November 3, 2026
Oct 5, 2026 04:05 PM Alamar Biosciences adds former Grail CEO to board, expands team
Oct 5, 2026 04:05 PM Alamar Biosciences Names Former Grail CEO Bob Ragusa to Board of Directors and Expands Leadership Team
Sep 24, 2026 06:51 PM Lancet Neurology Study Using Alamar Biosciences’ Technology Reveals Divergent Biological Responses to Alzheimer’s Treatment
Sep 24, 2026 05:43 AM TD Cowen Reiterates Buy Rating on Alamar Biosciences (ALMR)
View All Articles

Entities mentioned with ALMR

View All Entities